21.08.2015 Views

Vascular Access in Hemodialysis: the 2006 KDOQI ... - Network 6

Vascular Access in Hemodialysis: the 2006 KDOQI ... - Network 6

Vascular Access in Hemodialysis: the 2006 KDOQI ... - Network 6

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CPG 7 Prevention and Treatment ofCa<strong>the</strong>ter and Port Complications7.3 Methods that should be used to treat adysfunctional or nonfunctional ca<strong>the</strong>ter or port<strong>in</strong>clude:7.3.1 Reposition<strong>in</strong>g of a malpositioned ca<strong>the</strong>ter; (B)7.3.2 Thrombolytics, us<strong>in</strong>g ei<strong>the</strong>r an <strong>in</strong>tralum<strong>in</strong>allytic, <strong>in</strong>tradialytic lock protocol or an<strong>in</strong>traca<strong>the</strong>ter thrombolytic <strong>in</strong>fusion or<strong>in</strong>terdialytic lock (B)7.3.3 Ca<strong>the</strong>ter exchange with sheath disruption whenappropriate. (B)CPG7 Prevention and Treatment ofCa<strong>the</strong>ter and Port Complications7.4 Treatment of an <strong>in</strong>fected HD ca<strong>the</strong>ter or portshould be based on <strong>the</strong> type and extent of<strong>in</strong>fection.7.4.1 All ca<strong>the</strong>ter-related <strong>in</strong>fections, except forca<strong>the</strong>ter exit-site <strong>in</strong>fections, should beaddressed by <strong>in</strong>itiat<strong>in</strong>g parenteraltreatment with an antibiotic(s) appropriate for <strong>the</strong>organism(s) suspected. (A)7.4.2 Def<strong>in</strong>itive antibiotic <strong>the</strong>rapy should be based on<strong>the</strong> organism(s) isolated. (A)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!